Vytrus Biotech S.A. (VYT) — Financial Flexibility Index
Vytrus Biotech S.A. (VYT) has a Financial Flexibility Index of 0.22x as of December 2022. Free cash flow of €719.71K (operating CF €225.55K minus capex €494.16K) represents 0% of total liabilities (€3.25 Million). Check Vytrus Biotech S.A. (VYT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vytrus Biotech S.A. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Vytrus Biotech S.A. across 6 annual periods. For the full cash flow conversion analysis, see Vytrus Biotech S.A. operating cash flow efficiency.
Annual Financial Flexibility Index for Vytrus Biotech S.A. (2020–2025)
Year-by-year free cash flow to debt coverage for Vytrus Biotech S.A.. Explore Vytrus Biotech S.A. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.51x | €6.58 Million | €3.90 Million | €4.35 Million | ▲ +90.3% |
| 2024 | 0.79x | €3.05 Million | €1.84 Million | €3.84 Million | ▲ +54.2% |
| 2023 | 0.51x | €2.07 Million | €904.39K | €4.02 Million | ▲ +132.5% |
| 2022 | 0.22x | €719.71K | €225.55K | €3.25 Million | ▼ -9.8% |
| 2021 | 0.25x | €719.74K | €447.92K | €2.93 Million | ▲ +520.1% |
| 2020 | 0.04x | €102.86K | €-132.47K | €2.60 Million | — |